Dr. Reddy's Laboratories LimitedRDYNYSE
LOADING
|||
Net Income Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
1.37%
↓ 100% below average
Average (39q)
3912.74%
Historical baseline
Range
High:102021.15%
Low:-100.73%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 1.37% |
| Q2 2025 | -11.04% |
| Q1 2025 | 12.77% |
| Q4 2024 | 12.59% |
| Q3 2024 | -9.82% |
| Q2 2024 | 6.50% |
| Q1 2024 | -5.21% |
| Q4 2023 | 7602.73% |
| Q3 2023 | -98.72% |
| Q2 2023 | 11925.80% |
| Q1 2023 | -99.06% |
| Q4 2022 | 8843.99% |
| Q3 2022 | -98.83% |
| Q2 2022 | 102021.15% |
| Q1 2022 | -99.84% |
| Q4 2021 | 5176.73% |
| Q3 2021 | -97.65% |
| Q2 2021 | 11381.09% |
| Q1 2021 | -74.89% |
| Q4 2020 | 93.18% |
| Q3 2020 | -98.23% |
| Q2 2020 | -24.20% |
| Q1 2020 | 9654.94% |
| Q4 2019 | -100.73% |
| Q3 2019 | 64.83% |
| Q2 2019 | 52.58% |
| Q1 2019 | -10.47% |
| Q4 2018 | -3.69% |
| Q3 2018 | 10.46% |
| Q2 2018 | 50.93% |
| Q1 2018 | -9.63% |
| Q4 2017 | 17.37% |
| Q3 2017 | 382.06% |
| Q2 2017 | -81.09% |
| Q1 2017 | -33.52% |
| Q4 2016 | 59.36% |
| Q3 2016 | 133.57% |
| Q2 2016 | 69.30% |
| Q1 2016 | -87.12% |
| Q4 2015 | -19.76% |